An interventional study of Eye Empower and Placebo in Dry Eye and Eye Fatigue, sponsored by Bio Nature Health. Completed at 1 site in United States. Open to participants aged 45 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-14.
Sponsored by Bio Nature Health · Not applicable, Interventional, and Treatment
This is a 4-week virtual randomized, triple-blinded, placebo-controlled clinical trial evaluating the safety and efficacy of Eye Empower, an oral supplement, in adults aged 45 or older experiencing dry eyes, irritation, and fatigue. Participants take 3 capsules daily and complete self-reported eye health questionnaires weekly.
1,366 studies on the registry are indexed under Dry Eye Syndromes; 207 are open to participants now.
This study's enrollment of 60 is close to the median of 60 across 1,129 interventional studies indexed under Dry Eye Syndromes.
Browse Dry Eye Syndromes studies →Bio Nature Health is the lead sponsor of 5 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Dry eyes, Irritated eyes, Eye fatigue
- Self-reported concerns about any of the following symptoms over the last 4 weeks: Sensitivity to blue light, Blurred vision, far or near, Red or itchy eyes, Eye inflammation
Exclusion Criteria:
Coumadin (Warfarin) Aspirin Plavix (Clopidogrel)
Dietary Supplement: Eye Empower
Dietary Supplement: Placebo
A multi-ingredient oral supplement formulated to support eye health. Daily dose (3 capsules).
Identical gelatin capsules filled with inert rice flour, administered in the same dosage (3 capsules daily).
Change in Eye Health Symptoms (Dryness, Irritation, Fatigue, and Visual Acuity)
Assessment of changes in eye dryness, irritation, fatigue, and visual acuity using a self-reported questionnaire administered weekly.
Time frame: Baseline, Week 1, Week 2, Week 3, Week 4
Change in Perceived Overall Eye Health
Evaluation of participants' self-reported overall eye health using a standardized questionnaire administered weekly throughout the study.
Time frame: Baseline, Week 1, Week 2, Week 3, Week 4
Ran from Nov 2024 to primary completion in Dec 2024, 1 month.
Of 113 industry-sponsored interventional studies with no phase under Dry Eye Syndromes, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 13. This study's 1 month is below that.
Counting every sponsor, half of 312 studies reached it within 10 months; a quarter within 4 and three quarters within 18.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.